Comparing Gadopentetate Dimeglumine vs Gadoterate Meglumine
| Gadopentetate dimeglumine | Gadoterate meglumine |
|
|---|
| Gadopentetate dimeglumine | Gadoterate meglumine |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for CNS Magnetic Resonance Imaging, Vascular Magnetic Resonance Imaging. Gadopentetate dimeglumine may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for CNS Magnetic Resonance Imaging. Gadoterate meglumine may also be used for purposes not listed in this medication guide. |
Related suggestions CNS Magnetic Resonance Imaging
|
|||||||
| More about Gadopentetate dimeglumine | More about Gadoterate meglumine | ||||||||
| Ratings & Reviews | |||||||||
|
Gadopentetate dimeglumine has an average rating of 1.0 out of 10 from a total of 1 ratings on Drugs.com. 0% of reviewers reported a positive effect, while 100% reported a negative effect. |
Gadoterate meglumine has an average rating of 2.9 out of 10 from a total of 8 ratings on Drugs.com. 13% of reviewers reported a positive effect, while 75% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
|
View all Gadoterate meglumine side effects |
|||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
|
N/A |
Lower cost generic |
||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Gadoterate meglumine prices |
||||||||
| Dosage Forms | |||||||||
|
N/A |
|
||||||||
| Brand Names | |||||||||
| Magnevist | Clariscan, Dotarem | ||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
1.6 hours |
15.1 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
|
||||||||
| Drug Interactions | |||||||||
|
A total of 44 drugs are known to interact with Gadopentetate dimeglumine:
|
A total of 40 drugs are known to interact with Gadoterate meglumine:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
N/A |
March 20, 2013 |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
|
N/A |
|||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.